Canada markets close in 4 hours 45 minutes

NeuroSense Therapeutics Ltd. (NRSN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.13000.0000 (0.00%)
As of 11:05AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
7,588
7,588
6,416
3,082
2,495
-
Selling General and Administrative
5,714
5,714
7,136
2,505
393
-
Total Operating Expenses
13,302
13,302
13,552
5,587
2,888
-
Operating Income or Loss
-13,302
-13,302
-13,552
-5,587
-2,888
-
Interest Expense
11
11
15
0
0
-
Total Other Income/Expenses Net
2,394
2,394
1,143
2,700
61
-
Income Before Tax
-11,280
-11,280
-12,340
-4,041
-2,828
-
Income from Continuing Operations
-11,280
-11,280
-12,340
-4,041
-2,828
-
Net Income
-11,280
-11,280
-12,340
-4,041
-2,828
-
Net Income available to common shareholders
-11,280
-11,280
-12,340
-4,041
-2,828
-
Basic EPS
-0.94
-
-1.07
-0.65
-0.26
-0.11
Diluted EPS
-0.94
-
-1.07
-0.65
-0.26
-0.11
Basic Average Shares
12,307
-
11,505
6,243
10,944
10,944
Diluted Average Shares
12,307
-
11,505
6,243
10,944
10,944